Global Precision Medicine 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR062508641

Publication Date:

June 26, 2025

Pages:

136

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Precision Medicine market size was valued at US$ 146930 million in 2024 and is forecast to a readjusted size of USD 273270 million by 2031 with a CAGR of 9.4% during review period.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor鈥檚 blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
麻豆原创 competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
This report is a detailed and comprehensive analysis for global Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Precision Medicine market size and forecasts, in consumption value ($ Million), 2020-2031
Global Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Precision Medicine market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Precision Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Precision Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation, Biomrieux Sa, Cepheid, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Precision Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Diagnostics
Therapies
麻豆原创 segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
麻豆原创 segment by players, this report covers
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Precision Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Precision Medicine, with revenue, gross margin, and global market share of Precision Medicine from 2020 to 2025.
Chapter 3, the Precision Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Precision Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Precision Medicine.
Chapter 13, to describe Precision Medicine research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Precision Medicine by Type
1.3.1 Overview: Global Precision Medicine 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Precision Medicine Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Diagnostics
1.3.4 Therapies
1.4 Global Precision Medicine 麻豆原创 by Application
1.4.1 Overview: Global Precision Medicine 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Oncology
1.4.3 Neurosciences
1.4.4 Immunology
1.4.5 Respiratory
1.4.6 Others
1.5 Global Precision Medicine 麻豆原创 Size & Forecast
1.6 Global Precision Medicine 麻豆原创 Size and Forecast by Region
1.6.1 Global Precision Medicine 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Precision Medicine 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Precision Medicine 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Precision Medicine 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Precision Medicine 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Precision Medicine 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Precision Medicine 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Precision Medicine Product and Solutions
2.1.4 Johnson & Johnson Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Precision Medicine Product and Solutions
2.2.4 Roche Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Roche Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Precision Medicine Product and Solutions
2.3.4 Labcorp Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 Abbott Laboratories
2.4.1 Abbott Laboratories Details
2.4.2 Abbott Laboratories Major Business
2.4.3 Abbott Laboratories Precision Medicine Product and Solutions
2.4.4 Abbott Laboratories Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Abbott Laboratories Recent Developments and Future Plans
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Precision Medicine Product and Solutions
2.5.4 Novartis Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Novartis Recent Developments and Future Plans
2.6 Illumina
2.6.1 Illumina Details
2.6.2 Illumina Major Business
2.6.3 Illumina Precision Medicine Product and Solutions
2.6.4 Illumina Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Illumina Recent Developments and Future Plans
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business
2.7.3 GE Healthcare Precision Medicine Product and Solutions
2.7.4 GE Healthcare Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 GE Healthcare Recent Developments and Future Plans
2.8 Intel Corporation
2.8.1 Intel Corporation Details
2.8.2 Intel Corporation Major Business
2.8.3 Intel Corporation Precision Medicine Product and Solutions
2.8.4 Intel Corporation Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Intel Corporation Recent Developments and Future Plans
2.9 Biomrieux Sa
2.9.1 Biomrieux Sa Details
2.9.2 Biomrieux Sa Major Business
2.9.3 Biomrieux Sa Precision Medicine Product and Solutions
2.9.4 Biomrieux Sa Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Biomrieux Sa Recent Developments and Future Plans
2.10 Cepheid
2.10.1 Cepheid Details
2.10.2 Cepheid Major Business
2.10.3 Cepheid Precision Medicine Product and Solutions
2.10.4 Cepheid Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Cepheid Recent Developments and Future Plans
2.11 IBM
2.11.1 IBM Details
2.11.2 IBM Major Business
2.11.3 IBM Precision Medicine Product and Solutions
2.11.4 IBM Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 IBM Recent Developments and Future Plans
2.12 Qiagen
2.12.1 Qiagen Details
2.12.2 Qiagen Major Business
2.12.3 Qiagen Precision Medicine Product and Solutions
2.12.4 Qiagen Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Qiagen Recent Developments and Future Plans
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business
2.13.3 Thermo Fisher Scientific Precision Medicine Product and Solutions
2.13.4 Thermo Fisher Scientific Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.14 Randox Laboratories
2.14.1 Randox Laboratories Details
2.14.2 Randox Laboratories Major Business
2.14.3 Randox Laboratories Precision Medicine Product and Solutions
2.14.4 Randox Laboratories Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Randox Laboratories Recent Developments and Future Plans
2.15 Almac Group
2.15.1 Almac Group Details
2.15.2 Almac Group Major Business
2.15.3 Almac Group Precision Medicine Product and Solutions
2.15.4 Almac Group Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Almac Group Recent Developments and Future Plans
2.16 Healthcore
2.16.1 Healthcore Details
2.16.2 Healthcore Major Business
2.16.3 Healthcore Precision Medicine Product and Solutions
2.16.4 Healthcore Precision Medicine Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Healthcore Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Precision Medicine Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Precision Medicine by Company Revenue
3.2.2 Top 3 Precision Medicine Players 麻豆原创 Share in 2024
3.2.3 Top 6 Precision Medicine Players 麻豆原创 Share in 2024
3.3 Precision Medicine 麻豆原创: Overall Company Footprint Analysis
3.3.1 Precision Medicine 麻豆原创: Region Footprint
3.3.2 Precision Medicine 麻豆原创: Company Product Type Footprint
3.3.3 Precision Medicine 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Precision Medicine Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Precision Medicine 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Precision Medicine Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Precision Medicine 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Precision Medicine Consumption Value by Type (2020-2031)
6.2 North America Precision Medicine 麻豆原创 Size by Application (2020-2031)
6.3 North America Precision Medicine 麻豆原创 Size by Country
6.3.1 North America Precision Medicine Consumption Value by Country (2020-2031)
6.3.2 United States Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Precision Medicine Consumption Value by Type (2020-2031)
7.2 Europe Precision Medicine Consumption Value by Application (2020-2031)
7.3 Europe Precision Medicine 麻豆原创 Size by Country
7.3.1 Europe Precision Medicine Consumption Value by Country (2020-2031)
7.3.2 Germany Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Precision Medicine Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Precision Medicine Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Precision Medicine 麻豆原创 Size by Region
8.3.1 Asia-Pacific Precision Medicine Consumption Value by Region (2020-2031)
8.3.2 China Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Precision Medicine Consumption Value by Type (2020-2031)
9.2 South America Precision Medicine Consumption Value by Application (2020-2031)
9.3 South America Precision Medicine 麻豆原创 Size by Country
9.3.1 South America Precision Medicine Consumption Value by Country (2020-2031)
9.3.2 Brazil Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Precision Medicine Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Precision Medicine Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Precision Medicine 麻豆原创 Size by Country
10.3.1 Middle East & Africa Precision Medicine Consumption Value by Country (2020-2031)
10.3.2 Turkey Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Precision Medicine 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Precision Medicine 麻豆原创 Drivers
11.2 Precision Medicine 麻豆原创 Restraints
11.3 Precision Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Precision Medicine Industry Chain
12.2 Precision Medicine Upstream Analysis
12.3 Precision Medicine Midstream Analysis
12.4 Precision Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.